Literature DB >> 17694359

Prostaglandin H synthase isoenzyme distribution in the gingival tissue of patients with periodontitis: pronounced expression adjacent to gram-positive bacteria.

J S McDonald1, P F Cavanaugh, L J Pavelic, R J Limardi, J L Gluckman, Z P Pavelic.   

Abstract

Prostaglandin (PGE(2)) is an inflammatory mediator that plays a critical role in the pathogenesis of periodontal disease. Prostaglandin H synthase (PGHS) a rate-limiting enzyme in PGE(2) biosynthesis exists as two separate isoforms (PGHS-1 and PGHS-2). We have previously demonstrated that both isoforms are generally present in the gingival tissue of periodontitis patients. This study explores in greater detail the variable distribution of each isoenzyme in both inflamed and non-inflamed gingival tissues of patients with periodontitis, and the relationship to adjacent bacteria. Although the positive staining for PGHS-1 was never as intense as for PGHS-2 in the same tissue specimen, either in inflamed or non-inflamed tissues, there was strong staining for both isoenzymes in the epithelium. The keratin layer did not stain. Non-keratinizing crevicular and junctional epithelium contained both isoenzymes through their full thickness in both inflamed and non-inflamed tissues. Pronounced staining of PGHS-2 was evident in the epithelia adjacent to Gram-positively stained organisms. In non-inflamed tissue, PGHS-1 and PGHS-2 were particularly evident in the spinous cell layer; however, fewer of the fibroblasts, endothelial cells, and resident mononuclear inflammatory cells stained positively for PGHS-1 as compared to PGHS-2, but this was less apparent in the inflamed tissues. The immunohistochemical staining patterns indicate that both crevicular and gingival epithelium are important sources of prostaglandin production in the gingival tissue of patients with periodontitis and that bacteria entrapped near to these sites may be important in promoting expression of inducible PGHS-2.

Entities:  

Year:  1997        PMID: 17694359     DOI: 10.1007/s10787-997-0019-4

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  18 in total

Review 1.  Periodontal disease.

Authors:  R C Williams
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

2.  The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss.

Authors:  S Offenbacher; B M Odle; T E Van Dyke
Journal:  J Periodontal Res       Date:  1986-03       Impact factor: 4.419

Review 3.  The role of inflammatory mediators in the pathogenesis of periodontal disease.

Authors:  R C Page
Journal:  J Periodontal Res       Date:  1991-05       Impact factor: 4.419

Review 4.  Modulation of host PGE2 secretion as a determinant of periodontal disease expression.

Authors:  S Offenbacher; P A Heasman; J G Collins
Journal:  J Periodontol       Date:  1993-05       Impact factor: 6.993

5.  Regulation of human peripheral blood monocyte collagenase by prostaglandins and anti-inflammatory drugs.

Authors:  L M Wahl; L L Lampel
Journal:  Cell Immunol       Date:  1987-04-01       Impact factor: 4.868

6.  Interleukin-1 beta and interleukin-1 alpha stimulate the plasminogen activator activity and prostaglandin E2 levels of human synovial cells.

Authors:  T Leizer; B J Clarris; P E Ash; J van Damme; J Saklatvala; J A Hamilton
Journal:  Arthritis Rheum       Date:  1987-05

7.  Measurement of interleukin-1 alpha and -1 beta in gingival crevicular fluid: implications for the pathogenesis of periodontal disease.

Authors:  M P Masada; R Persson; J S Kenney; S W Lee; R C Page; A C Allison
Journal:  J Periodontal Res       Date:  1990-05       Impact factor: 4.419

8.  Independent regulation of plasminogen activator inhibitor 2 and plasminogen activator inhibitor 1 in human synovial fibroblasts.

Authors:  J A Hamilton; D Cheung; E L Filonzi; D S Piccoli; J Wojta; M Gallichio; K McGrath; K Last
Journal:  Arthritis Rheum       Date:  1992-12

9.  Levels of interleukin 1 beta in tissue from sites of active periodontal disease.

Authors:  P Stashenko; P Fujiyoshi; M S Obernesser; L Prostak; A D Haffajee; S S Socransky
Journal:  J Clin Periodontol       Date:  1991-08       Impact factor: 8.728

10.  Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis.

Authors:  M K Jeffcoat; R Page; M Reddy; A Wannawisute; P Waite; K Palcanis; R Cogen; R C Williams; C Basch
Journal:  J Periodontal Res       Date:  1991-09       Impact factor: 4.419

View more
  1 in total

1.  Local delivery of a CXCR3 antagonist decreases the progression of bone resorption induced by LPS injection in a murine model.

Authors:  Soma Lari; Sarah Hiyari; Davi Neto de Araújo Silva; Beatriz de Brito Bezerra; Makiko Ishii; Sepehr Monajemzadeh; Zhong-Kai Cui; Sotirios Tetradis; Min Lee; Flavia Q Pirih
Journal:  Clin Oral Investig       Date:  2022-04-25       Impact factor: 3.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.